News Archive

September 4, 2024

Keeping It Simple: What Really Matters For Emerging Enterprises

  • From the Trenches
Read more
August 21, 2024

A Biotech Midsummer’s Madness

  • From the Trenches
Read more
August 8, 2024

Intellia’s gene editing therapy succeeds in Phase 2 genetic swelling condition study

  • Portfolio Company News
Read more
August 5, 2024

Medicinal Chemistry In The Age Of Artificial Intelligence

  • From the Trenches
Read more
July 31, 2024

A Primer on Early-Stage Biotech VC

  • From the Trenches
Read more